We are live on
!
Find out more
SCM
Sterling Capital Management Portfolio holdings
AUM
$5.28B
1-Year Est. Return
23.15%
This Fund
S&P 500
This Quarter
Est. Return
+6.09%
1 Year Est. Return
+23.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11.1B
AUM Growth
+$425M
(+4%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
13.2%
Holding
1,037
New
126
Increased
274
Reduced
260
Closed
166
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$87.1M |
| 2 |
Medtronic
MDT
|
+$63.8M |
| 3 |
NCR Voyix
VYX
|
+$35.3M |
| 4 |
Western Union
WU
|
+$28.9M |
| 5 |
HCA Healthcare
HCA
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$74.9M |
| 2 |
Ryman Hospitality Properties
RHP
|
+$48.9M |
| 3 |
Qualcomm
QCOM
|
+$44.5M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$34.6M |
| 5 |
Deckers Outdoor
DECK
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.55% |
| 2 | Healthcare | 16.16% |
| 3 | Technology | 14.7% |
| 4 | Consumer Discretionary | 9.66% |
| 5 | Industrials | 9.4% |
Similar funds
FMWA
DRZID
WL
CBUSF
SDIC
DDC
DPL
KACA
Sterling Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Sterling Capital Management held 1,037 positions worth $11.1B, up 4% from $10.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Sterling Capital Management's Q4 2017 filing shows 126 new, 274 increased, 260 reduced and 166 closed positions. Its largest new stake was Analog Devices: 982,934 shares worth $87.5M. The largest sale was Novartis, an estimated $74.9M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
- Sterling Capital Management's largest Q4 2017 buy was Analog Devices: 982,934 shares worth $87.5M.
- Sterling Capital Management added most to Medtronic in Q4 2017, an estimated $63.8M increase.
- Sterling Capital Management's biggest Q4 2017 reduction was Novartis, cutting an estimated $74.9M.
- Sterling Capital Management fully exited Parexel International Corp in Q4 2017, selling an estimated $34.6M.
- Sterling Capital Management's ten largest holdings make up 13% of its $11.1B portfolio in Q4 2017.
- Sterling Capital Management opened 126 new positions and closed 166 in Q4 2017.
- Sterling Capital Management's portfolio value rose 4% quarter-over-quarter to $11.1B.
Based on Sterling Capital Management's 13F filing for Q4 2017, filed 15 Feb 2018.